title: Immunotherapy and metastic renal cell cancer.
authors.forename: C
authors.initials: C
authors.lastname: Buzio
authors.forename: G
authors.initials: G
authors.lastname: De Palma
authors.forename: C
authors.initials: C
authors.lastname: Caminiti
authors.forename: M A
authors.initials: MA
authors.lastname: Cattabiani
authors.forename: L
authors.initials: L
authors.lastname: Manenti
mesh_terms: D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D007370:Interferon Type I; D007376:Interleukin-2; D011994:Recombinant Proteins